Fenofibrate suppressed proliferation and migration of human neuroblastoma cells via oxidative stress dependent of TXNIP upregulation

Biochemical and Biophysical Research Communications

Volumn 460, Issue 4, 2015, Pages 983-988

  Su, Cunjin ^a   Shi, Aiming ^a   Cao, Guowen ^a   Tao, Tao ^b   Chen, Ruidong ^a   Hu, Zhanhong ^a   Shen, Zhu ^a   Tao, Hong ^a   Cao, Bin ^a   Hu, Duanmin ^a   Bao, Junjie ^a  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Apoptosis; Fenofibrate; Neuroblastoma; Oxidative stress; SHSY5Y; TXNIP

Indexed keywords

CARRIER PROTEIN; FENOFIBRATE; SMALL INTERFERING RNA; TXNIP PROTEIN, HUMAN;

CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

BASE SEQUENCE; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FENOFIBRATE; HUMANS; NEUROBLASTOMA; OXIDATIVE STRESS; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84937762454     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.03.138     Document Type: Article

References (25)

1. C. Bottino, A. Dondero, F. Bellora, L. Moretta, F. Locatelli, V. Pistoia, A. Moretta, and R. Castriconi Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches Front. Immunol. 5 2014 56
2. T. Monclair, G.M. Brodeur, P.F. Ambros, H.J. Brisse, G. Cecchetto, K. Holmes, M. Kaneko, W.B. London, K.K. Matthay, J.G. Nuchtern, S.D. von, T. Simon, S.L. Cohn, and A.D. Pearson The International neuroblastoma risk group (INRG) staging system: an INRG task force report J. Clin. Oncol. 27 2009 298 303
3. M.A. Smith, N.L. Seibel, S.F. Altekruse, L.A. Ries, D.L. Melbert, M. O'Leary, F.O. Smith, and G.H. Reaman Outcomes for children and adolescents with cancer: challenges for the twenty-first century J. Clin. Oncol. 28 2010 2625 2634
4. M. Lella, and K. Indira A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia J. Adv. Pharm. Technol. Res. 4 2013 166 170
5. E. Binello, E. Mormone, L. Emdad, H. Kothari, and I.M. Germano Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells J. Neurooncol. 117 2014 225 234
6. H. Liang, P. Kowalczyk, J.J. Junco, S.H.L. Klug-De, G. Malik, S.J. Wei, and T.J. Slaga Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPARalpha receptors Mol. Carcinog. 53 2014 753 763
7. H. Zhao, C. Zhu, C. Qin, T. Tao, J. Li, G. Cheng, P. Li, Q. Cao, X. Meng, X. Ju, P. Shao, L. Hua, M. Gu, and C. Yin Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP Biochem. Biophys. Res. Commun. 432 2013 320 325
8. D. Yamasaki, N. Kawabe, H. Nakamura, K. Tachibana, K. Ishimoto, T. Tanaka, H. Aburatani, J. Sakai, T. Hamakubo, T. Kodama, and T. Doi Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARalpha-independent mechanisms Eur. J. Cell. Biol. 90 2011 657 664
9. K.L. Zhang, L. Han, L.Y. Chen, Z.D. Shi, M. Yang, Y. Ren, L.C. Chen, J.X. Zhang, P.Y. Pu, and C.S. Kang Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas Cancer Lett. 342 2014 139 149
10. D.F. Han, J.X. Zhang, W.J. Wei, T. Tao, Q. Hu, Y.Y. Wang, X.F. Wang, N. Liu, and Y.P. You Fenofibrate induces G/G phase arrest by modulating the PPARalpha/FoxO1/p27 pathway in human glioblastoma cells Tumour Biol. 2015
11. E. Wybieralska, K. Szpak, A. Gorecki, P. Bonarek, K. Miekus, J. Drukala, M. Majka, K. Reiss, Z. Madeja, and J. Czyz Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations Oncol. Rep. 26 2011 447 453
12. P. Nguyen, R.T. Awwad, D.D. Smart, D.R. Spitz, and D. Gius Thioredoxin reductase as a novel molecular target for cancer therapy Cancer Lett. 236 2006 164 174
13. E. Yoshihara, S. Masaki, Y. Matsuo, Z. Chen, H. Tian, and J. Yodoi Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases Front. Immunol. 4 2014 514
14. K. Gao, Y. Chi, W. Sun, M. Takeda, and J. Yao 5′-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway Mol. Pharmacol. 85 2014 460 471
15. C.M. Woolston, S. Madhusudan, I.N. Soomro, D.N. Lobo, A.M. Reece-Smith, S.L. Parsons, and S.G. Martin Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma Redox Biol. 1 2013 285 291
16. C.M. Woolston, L. Zhang, S.J. Storr, A. Al-Attar, M. Shehata, I.O. Ellis, S.Y. Chan, and S.G. Martin The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer Mod. Pathol. 25 2012 1106 1116
17. J.A. Morrison, L.A. Pike, S.B. Sams, V. Sharma, Q. Zhou, J.J. Severson, A.C. Tan, W.M. Wood, and B.R. Haugen Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer Mol. Cancer 13 2014 62
18. J. Zhou, Q. Yu, and W.J. Chng TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms Int. J. Biochem. Cell. Biol. 43 2011 1668 1673
19. X. Li, D. Zhen, X. Lu, H. Xu, Y. Shao, Q. Xue, Y. Hu, B. Liu, and W. Sun Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells-a possible trojan strategy against cancer Eur. J. Pharm. Biopharm. 75 2010 334 340
20. S.W. Kang, S. Lee, and E.K. Lee ROS and energy metabolism in cancer cells: alliance for fast growth Arch. Pharm. Res. 2015
21. B. Liu, W. Zhou, X. Chen, F. Xu, Y. Chen, J. Liu, Q. Zhang, S. Bao, N. Chen, M. Li, and R. Zhu Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-beta pathway Mol. Med. Rep. 11 2015 1609 1614
22. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp Thioredoxin-interacting protein links oxidative stress to inflammasome activation Nat. Immunol. 11 2010 136 140
23. F. Yamaguchi, Y. Hirata, H. Akram, K. Kamitori, Y. Dong, L. Sui, and M. Tokuda FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 BMC Cancer 13 2013 468
24. T. Li, Q. Zhang, J. Zhang, G. Yang, Z. Shao, J. Luo, M. Fan, C. Ni, Z. Wu, and X. Hu Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-kappaB pathway BMC Cancer 14 2014 96
25. S. Luanpitpong, P. Chanvorachote, C. Stehlik, W. Tse, P.S. Callery, L. Wang, and Y. Rojanasakul Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells Mol. Biol. Cell. 24 2013 858 869